- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Relapsing Remitting MS
Total 22275 results
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Sclerosis, Relapsing-RemittingItaly
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisPoland, Hungary, Turkey, Spain, Germany, United States, Canada, Switzerland, Russian Federation, Norway, Italy, Finland
-
MallinckrodtMallinckrodt ARD Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
Assiut UniversityUnknownSimvastatin Multiple Sclerosis
-
Mansoura University HospitalUnknownMultiple Sclerosis | Sexual DysfunctionEgypt
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
National Institute of Neurological Disorders and...CompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Patient-Centered Outcomes Research Institute; Universita degli Studi di GenovaTerminatedRelapsing Remitting Multiple SclerosisItaly
-
University of CalgaryAlberta Innovates Health SolutionsCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
Novartis PharmaceuticalsCompleted
-
BiogenAbbVieTerminatedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy, United States, Canada, Germany, Puerto Rico
-
BiogenAMS Advanced Medical Services GmbHCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Instituto de Investigación Sanitaria de la Fundación...Universidad Rey Juan CarlosCompletedUrinary Incontinence | Relapsing-Remitting Multiple SclerosisSpain
-
University Hospital, CaenCompletedMultiple SclerosisFrance
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
Isfahan University of Medical SciencesShiraz University of Medical SciencesCompleted
-
University of Colorado, DenverCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Teva Pharmaceutical Industries, Ltd.TerminatedRelapsing Remitting Multiple SclerosisCzechia, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
BayerCompleted
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
University of Wisconsin, MadisonNational Multiple Sclerosis SocietyCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Institut National de la Santé Et de la Recherche...UnknownMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
Merck KGaA, Darmstadt, GermanyMerck B.V., NetherlandsTerminated
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCzechia, Belgium
-
University of ChicagoGenzyme, a Sanofi CompanyCompleted
-
Dr. med. Micha LoebermannCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Dr. Frank BehrensSocraMetrics GmbHCompleted
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisKorea, Republic of, Taiwan, Czechia, Japan, Poland
-
Eli Lilly and CompanyCompletedRelapsing-Remitting Multiple SclerosisHungary, United States, France, Ukraine, Poland, Germany, Israel, Russian Federation, Czechia, Serbia, Romania, Slovakia, Bulgaria
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
University of VirginiaNational Multiple Sclerosis SocietyUnknownClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
University of California, San FranciscoMassachusetts General Hospital; Mayo Clinic; Baylor College of Medicine; Children... and other collaboratorsCompletedPediatric Multiple SclerosisUnited States
-
University of British ColumbiaGenzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisCanada
-
University Hospital MuensterBiogenCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Johns Hopkins UniversityWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
Dokuz Eylul UniversityCompletedMultiple Sclerosis, Relapsing-RemittingTurkey
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
BayerCompleted
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark